Evaluation of Cellular Responses to ChAdOx1-nCoV-19 and BNT162b2 VaccinationsArticle Published on 2023-05-012023-07-11 Journal: Annals of laboratory medicine [Category] COVID19(2023년), [키워드] Cellular responses humoral responses immunogenicity severe acute respiratory syndrome coronavirus 2 vaccination. [DOI] 10.3343/alm.2023.43.3.290 PMC 바로가기
Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workersClinical Trial Published on 2023-05-012023-06-24 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 신종인플루엔자, [키워드] clinical trial COVID-19 immunogenicity Influenza vaccination. [DOI] 10.1016/j.cmi.2022.12.008 PMC 바로가기 [Article Type] Clinical Trial
Factors affecting the immunogenicity of influenza vaccines in humanArticle Published on 2023-04-062023-06-24 Journal: BMC Infectious Diseases [Category] 신종인플루엔자, [키워드] immune response immunogenicity Influenza influenza vaccine vaccine effectiveness. [DOI] 10.1186/s12879-023-08158-3 PMC 바로가기
Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adultsClinical Trial Published on 2023-03-102023-07-11 Journal: Vaccine [Category] COVID19(2023년), [키워드] clinical trial COVID-19 vaccine immunogenicity preclinical study Recombinant spike protein Safety. [DOI] 10.1016/j.vaccine.2022.12.025 PMC 바로가기 [Article Type] Clinical Trial
One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France: first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohortObservational Study Published on 2023-03-012023-07-10 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), [키워드] COVID-19 Efficacy humoral Immunocompromised immunogenicity specific populations. [DOI] 10.1016/j.cmi.2022.10.009 PMC 바로가기 [Article Type] Observational Study
Dyslipidemia and SARS-CoV-2 spike antibody titres after the second and third doses of the BNT162b2 vaccine among healthcare workers in JapanArticle Published on 2023-03-012023-07-11 Journal: Diabetes/metabolism research and reviews [Category] COVID19(2023년), [키워드] COVID-19 dyslipidemia hypertriglyceridemia immunogenicity SARS-CoV-2 vaccine. [DOI] 10.1002/dmrr.3606 PMC 바로가기
Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort studyArticle Published on 2023-03-012023-07-11 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), [키워드] BNT162b2 ChAdOx1-S heterologous prime-boost immunogenicity Reactogenicity. [DOI] 10.1016/j.ijid.2022.12.034 PMC 바로가기
A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic countryClinical Trial Published on 2023-02-102023-05-31 Journal: Vaccine [Category] A형 간염, [키워드] Coadministration immunogenicity inactivated hepatitis A vaccine Live attenuated tetravalent dengue vaccine randomized trial Safety. [DOI] 10.1016/j.vaccine.2023.01.007 PMC 바로가기 [Article Type] Clinical Trial
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label TrialRandomized Controlled Trial Published on 2023-02-082023-06-14 Journal: Clinical Infectious Diseases: An Official Publicat [Category] Fulltext, 신종인플루엔자, [키워드] Flublok Quadrivalent Flucelvax Quadrivalent healthcare personnel immunogenicity influenza vaccines. [DOI] 10.1093/cid/ciac683 PMC 바로가기 [Article Type] Randomized Controlled Trial
Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trialClinical Trial Published on 2023-02-012023-06-20 Journal: Journal of medical virology [Category] Fulltext, MERS, [키워드] COVID-19 immunogenicity Noora vaccine Protein subunit Safety. SARS-CoV-2 [DOI] 10.1002/jmv.28097 PMC 바로가기 [Article Type] Clinical Trial